CymaBay Therapeutics to Report Third Quarter 2019 Financial Results on Tuesday, November 5

NEWARK, Calif., Oct. 28, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, today announced that it will host a conference call and live audio webcast on Tuesday, November 5, 2019 at 4:30 p.m. Eastern Time to discuss financial results for the third quarter and nine months ended September 30, 2019 and to provide a business update.

Click to view original post